|
|
Cancer Ignition-Properties
Bioactivity Guidance
By the
Cancer Essence,
effectively, there occurs a defect in a biologic of the cell which
biologic evolves into Defect Stressor so induces and sustains
cancerous condition. So far about 400 cancerous types have been
determined, with limited uniqueness to each type.
Attempts at developing chemical drug treatments have been on going;
and in fact, only recently there obtained a cancer case history in
which some drugs, albeit cocktail, have completely unexpectedly
cured the cancer, by which is meant the cancer was no longer found
on subsequent medical examination, as in the case of the colorectal
cancer treatment. Yet the curativeness of the known drugs and the
manner by which the Defect Stressor, more specifically, was
destroyed seems unexplained, as there has been no reaction mechanism
based explanation and the relation to any Defect Stressor.
In effect there has been no clear assertion of the role of boundary
either of the cancer mass, or cell cytoplasm, that have factored in
the suggested explanation of the curativeness of the observed cure.
The construction of a mechanism including both bio-condensation and
pure chemical reaction between the drug substances and the Defect
Stressor context would be insightful and serve as a good guidance
towards use of same drugs as bases of new drugs design for the cure
of other types of cancer
Yet it seems reasonable to infer that the outcome suggests that the
administered drug cocktail enabled an inadvertent targeting of the
intrinsic Defect Stressor of the specific class of colorectal
cancer. In effect establishing the curativeness of known cancer
cures in the context of a Cancer Ignition Hypothesis --derivative of
the Warburg
Hypothesis; as can be inferred from the elicitations of the
reaction mechanisms, vis-à-vis bioactivity, of a medication-drug and
the cancer-matrix biologics, would be empowering to medical
professionals engaged in the treatment of cancer.
The well-publicized cure of Colorectal Cancer offers a case history
for retroactively determining the bioactivity mechanism by which the
known cure worked: The bioreaction mechanism of the administered
drugs towards the destruction of the cancer-matrix biologics
including the Defect Stressor. The elicitation and compilation of
cure-contexts, being published on the
Cancer Treatment Bioactivity Analysis, would be invaluable for
guidance for future cure of same-type cancer. |